SCARB1 and nonpapillary renal cell carcinoma: Increased immunoreactivity with anti-apoA-I or anti-SR-BI antibodies, but not immunoreactivity with anti-apoB antibodies, significantly differentiated 175 ccRCC tissues from papillary RCC (Table 1).